Oral nano‐curcumin formulation efficacy in the management of mild to moderate outpatient COVID‐19: A randomized triple‐blind placebo‐controlled clinical trial

BACKGROUND: Curcumin, a natural polyphenolic compound, is proposed as a potential treatment option for patients with coronavirus disease by inhibiting the entry of virus to the cell, encapsulation of the virus and viral protease, as well as modulating various cellular signaling pathways. In this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadi, Reza, Salari, Soofia, Sharifi, Mohammad Davood, Reihani, Hamidreza, Rostamiani, Mohammad Bagher, Behmadi, Morteza, Taherzadeh, Zhila, Eslami, Saeed, Rezayat, Seyed Mahdi, Jaafari, Mahmoud Reza, Elyasi, Sepideh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358331/
https://www.ncbi.nlm.nih.gov/pubmed/34401058
http://dx.doi.org/10.1002/fsn3.2226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358331/
https://www.ncbi.nlm.nih.gov/pubmed/34401058
http://dx.doi.org/10.1002/fsn3.2226

Ejemplares similares